Shares in Spire Healthcare Group Plc (LSE:SPI) jumped more than 6% this morning after Sky News reported that buyout firm Bridgepoint is drawing up plans for a formal offer worth around 230p a share, valuing Britain's biggest private hospitals operator at more than £1 billion. According to Sky News, Bridgepoint, the former owner of Oasis Healthcare, the dentistry chain previously run by Spire's own chief executive Justin Ash, is serious about a bid, though a formal offer may not arrive before a Takeover Panel "put up or shut up" deadline of 5pm today.
Shares of Spire Inc. (NYSE: SR - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve ratings firms that are currently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and two have assigned a strong buy
Spire (SR) reported earnings 30 days ago. What's next for the stock?
Spire Inc. offers a compelling blend of quality, attractive valuation, and consistent dividend growth, nearing Dividend Aristocrat status. SR's primary growth drivers are the Piedmont Natural Gas acquisition and successful rate cases, supporting 7.5% EPS growth this year and 5%–7.5% long term. With a 3.8% yield, 4.8% five-year dividend CAGR, and a payout ratio near 63%, SR targets sustainable 5% dividend growth ahead.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Spire Inc. (SR) Q1 2026 Earnings Call Transcript
SR reports stronger-than-expected Q1 results, with rising revenues, improved operating income and higher earnings across key segments.
While the top- and bottom-line numbers for Spire (SR) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Spire (SR) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.34 per share a year ago.
SR is likely to report Q1 earnings results on Feb. 3, with new rates, lower interest costs and storage expansion in focus, even as higher O&M expenses loom.
Spire Healthcare Group Plc's (LSE:SPI) confirmation that it is in preliminary talks with Bridgepoint and Triton has sharpened focus on the company's valuation as speculation builds around a potential bid. Analysts at Panmure Liberum and Peel Hunt both welcomed the update, seeing the named suitors as credible and the discussions as evidence of genuine interest.